Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

36.86
Delayed Data
As of Sep 23
 -0.66 / -1.76%
Today’s Change
31.08
Today|||52-Week Range
80.25
-52.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-52.3M-63.9M-13.7M1.9M
 
 
 
 
 
Depreciation5.6M5.7M10.0M11.5M
 
 
 
 
 
Total Other Cash Flow6.4M19.4M29.6M38.0M
 
 
 
 
 
Funds From Operations-40.2M-38.8M25.9M51.3M
 
 
 
 
 
Funds From/For Other Operating Expenses28.9M4.0M-514.0K23.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-69.1M-42.8M26.4M27.8M
 
 
 
 
 
 
InvestingIncrease In Investments-54.0M-114.3M-164.3M-189.1M
 
 
 
 
 
Decrease In Investments53.1M85.6M80.3M217.2M
 
 
 
 
 
Capital Expenditures-18.3M-12.8M-21.9M-41.3M
 
 
 
 
 
Fixed Asset Disposal1.0K0.000.00--
 
 
Other Investing - Uses-10.3M-2.0M-13.4M-7.1M
 
 
 
 
 
Net Cash Flow Investing-29.5M-43.6M-119.3M-20.2M
 
 
 
 
 
 
FinancingShort Term Borrowings-1.1M-434.0K-970.0K-276.0K
 
 
 
 
 
Long Term Borrowings26.1M112.8M0.000.00
 
 
 
Long Term Debt Reduction-26.3M-27.5M0.00-1.5M
 
 
 
 
Net Proceeds Stock Sale63.7M3.9M118.9M12.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing62.5M88.7M117.9M10.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-36.0M2.4M25.0M18.0M